Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT00560651

German Corneal Cross Linking Register

Conditions: Keratoconus

Sex: All
Healthy volunteers: No
Enrollment: 356
Sponsor: Suphi Taneri

Location: University of Saar Homburg

Summary

Corneal Cross Linking is new treatment modality for patients with keratoconus. A keratoconus is characterized by progressive bulging and thinning of the eye's cornea. Keratoconus is a potentially severely sight impairing condition that may necessitate corneal transplantation in the progressive state. Corneal Cross Linking is designed to * increase the cornea's mechanical stability * to stop progression of bulging and thinning of the cornea * to prevent the need for corneal transplantation Corneal Cross Linking is performed by 1. Applying Riboflavin (Vitamin B2) eye drops every 2 minutes for 30 minutes to the cornea 2. Illuminating the cornea with UV-light This register of Corneal Cross Linking procedures performed in Germany serves to * gather long-term results * detect rare complications and side-effects * evaluate the efficacy in a large number of patients

Eligibility Criteria

Inclusion Criteria: * Patients diagnosed with keratokonus and treated with corneal cross Linking in Germany Exclusion Criteria: * Non-ectatic conditions

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT00560651). StuddyBuddy aggregates publicly available trial information.